Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

Gilead Sciences Shares Outstanding 2006-2021 | GILD

Gilead Sciences shares outstanding history from 2006 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Gilead Sciences shares outstanding for the quarter ending June 30, 2021 were 1.260B, a 0.4% increase year-over-year.
  • Gilead Sciences 2020 shares outstanding were 1.263B, a 1.1% decline from 2019.
  • Gilead Sciences 2019 shares outstanding were 1.277B, a 2.37% decline from 2018.
  • Gilead Sciences 2018 shares outstanding were 1.308B, a 0.83% decline from 2017.
  
Gilead Sciences Annual Shares Outstanding
(Millions of Shares)
2020 1,263
2019 1,277
2018 1,308
2017 1,319
2016 1,358
2015 1,521
2014 1,647
2013 1,695
2012 1,583
2011 1,580
2010 1,747
2009 1,868
2008 1,918
2007 1,929
2006 1,836
2005 1,897
Gilead Sciences Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 1,260
2021-03-31 1,262
2020-12-31 1,263
2020-09-30 1,261
2020-06-30 1,255
2020-03-31 1,270
2019-12-31 1,277
2019-09-30 1,267
2019-06-30 1,277
2019-03-31 1,283
2018-12-31 1,308
2018-09-30 1,307
2018-06-30 1,308
2018-03-31 1,320
2017-12-31 1,319
2017-09-30 1,319
2017-06-30 1,317
2017-03-31 1,320
2016-12-31 1,358
2016-09-30 1,339
2016-06-30 1,355
2016-03-31 1,412
2015-12-31 1,521
2015-09-30 1,503
2015-06-30 1,540
2015-03-31 1,569
2014-12-31 1,647
2014-09-30 1,637
2014-06-30 1,664
2014-03-31 1,680
2013-12-31 1,695
2013-09-30 1,692
2013-06-30 1,695
2013-03-31 1,665
2012-12-31 1,583
2012-09-30 1,585
2012-06-30 1,561
2012-03-31 1,555
2011-12-31 1,580
2011-09-30 1,563
2011-06-30 1,602
2011-03-31 1,624
2010-12-31 1,747
2010-09-30 1,694
2010-06-30 1,798
2010-03-31 1,857
2009-12-31 1,868
2009-09-30 1,865
2009-06-30 1,869
2009-03-31 1,885
2008-12-31 1,918
2008-09-30 1,921
2008-06-30 1,931
2008-03-31 1,933
2007-12-31 1,929
2007-09-30 1,918
2007-06-30 1,936
2007-03-31 1,925
2006-12-31 1,836
2006-09-30 1,830
2006-06-30 1,905
2006-03-31 1,927
2005-12-31 1,897
2005-09-30 1,904
2005-06-30 1,890
2005-03-31 1,870
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $89.434B $24.689B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $177.867B 54.94
Bristol Myers Squibb (BMY) United States $136.060B 9.06
Amgen (AMGN) United States $123.428B 13.37
CSL (CSLLY) Australia $102.552B 0.00
BioNTech SE (BNTX) Germany $90.374B 19.50
Regeneron Pharmaceuticals (REGN) United States $69.861B 11.99
Illumina (ILMN) United States $66.003B 74.99
Vertex Pharmaceuticals (VRTX) United States $48.539B 18.86
Biogen (BIIB) United States $44.664B 12.26
BeiGene (BGNE) Cayman Islands $35.765B 0.00
Seagen (SGEN) United States $27.940B 47.11
Genmab (GNMSF) Denmark $27.875B 69.68
Genmab (GMAB) Denmark $27.770B 68.19
Horizon Therapeutics Public (HZNP) Ireland $24.385B 23.12
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.605B 0.00
Bio-Techne Corp (TECH) United States $20.691B 93.05
Exact Sciences (EXAS) United States $17.675B 0.00
Novavax (NVAX) United States $17.673B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.645B 0.00
Incyte (INCY) United States $16.571B 39.29
Repligen (RGEN) United States $16.465B 125.47
BioMarin Pharmaceutical (BMRN) United States $14.026B 100.66
Guardant Health (GH) United States $12.863B 0.00
QIAGEN (QGEN) Netherlands $12.345B 20.91
Zai Lab (ZLAB) China $12.059B 0.00
Intellia Therapeutics (NTLA) United States $11.306B 0.00
CureVac (CVAC) Germany $10.301B 0.00
Ascendis Pharma (ASND) Denmark $8.980B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.955B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.948B 22.98
Mirati Therapeutics (MRTX) United States $8.725B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.147B 0.00
Vir Biotechnology (VIR) United States $6.871B 0.00
Sarepta Therapeutics (SRPT) United States $6.837B 0.00
Beam Therapeutics (BEAM) United States $6.772B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.528B 0.00
Exelixis (EXEL) United States $6.471B 70.83
Denali Therapeutics (DNLI) United States $6.451B 182.86
Fate Therapeutics (FATE) United States $6.331B 0.00
Legend Biotech (LEGN) United States $6.033B 0.00
Blueprint Medicines (BPMC) United States $6.031B 17.02
Halozyme Therapeutics (HALO) United States $5.985B 24.45
NeoGenomics (NEO) United States $5.826B 789.67
Twist Bioscience (TWST) United States $5.613B 0.00
Certara (CERT) United States $5.579B 0.00
AbCellera Biologics (ABCL) $5.518B 0.00
Adaptive Biotechnologies (ADPT) United States $5.405B 0.00
I-Mab (IMAB) China $5.244B 0.00
Alkermes (ALKS) Ireland $4.806B 141.86
Arvinas (ARVN) United States $4.634B 0.00
Editas Medicine (EDIT) United States $4.164B 0.00
Reata Pharmaceuticals (RETA) United States $3.914B 0.00
Arena Pharmaceuticals (ARNA) United States $3.661B 0.00
Galapagos (GLPG) Belgium $3.623B 0.00
SpringWorks Therapeutics (SWTX) United States $3.578B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.312B 0.00
Prothena (PRTA) Ireland $3.304B 0.00
ALX Oncology Holdings (ALXO) United States $3.264B 0.00
Insmed (INSM) United States $3.096B 0.00
Emergent Biosolutions (EBS) United States $3.086B 7.44
Apellis Pharmaceuticals (APLS) United States $2.958B 0.00
Amicus Therapeutics (FOLD) United States $2.953B 0.00
Intra-Cellular Therapies (ITCI) United States $2.806B 0.00
Cytokinetics (CYTK) United States $2.797B 0.00
Heska (HSKA) United States $2.708B 519.08
ACADIA Pharmaceuticals (ACAD) United States $2.590B 0.00
Myriad Genetics (MYGN) United States $2.546B 0.00
Celldex Therapeutics (CLDX) United States $2.477B 0.00
Morphic Holding (MORF) United States $2.435B 0.00
Sorrento Therapeutics (SRNE) United States $2.409B 0.00
C4 Therapeutics (CCCC) United States $2.398B 0.00
Instil Bio (TIL) United States $2.391B 0.00
Arcus Biosciences (RCUS) United States $2.358B 0.00
Vericel (VCEL) United States $2.311B 275.28
Ligand Pharmaceuticals (LGND) United States $2.251B 32.92
Atea Pharmaceuticals (AVIR) United States $2.246B 0.00
Seer (SEER) $2.220B 0.00
Protagonist Therapeutics (PTGX) United States $2.194B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.115B 36.02
Alector (ALEC) United States $2.059B 0.00
Amarin (AMRN) Ireland $2.044B 517.00
Myovant Sciences (MYOV) United Kingdom $2.042B 0.00
Castle Biosciences (CSTL) United States $1.918B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.912B 0.00
Revance Therapeutics (RVNC) United States $1.903B 0.00
REGENXBIO (RGNX) United States $1.901B 0.00
NGM Biopharmaceuticals (NGM) United States $1.844B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.843B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.696B 5.77
Zymeworks (ZYME) Canada $1.675B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.663B 0.00
Dynavax Technologies (DVAX) United States $1.657B 0.00
Global Blood Therapeutics (GBT) United States $1.645B 0.00
MorphoSys AG (MOR) Germany $1.640B 0.00
Inovio Pharmaceuticals (INO) United States $1.630B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.615B 0.00
Codexis (CDXS) United States $1.591B 0.00
Nurix Therapeutics (NRIX) United States $1.589B 0.00
Berkeley Lights (BLI) United States $1.579B 0.00
Kadmon Holdings (KDMN) United States $1.520B 0.00
MaxCyte (MXCT) United States $1.503B 0.00
Ocugen (OCGN) United States $1.499B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.477B 0.00
Bionano Genomics (BNGO) United States $1.477B 0.00
Genetron Holdings (GTH) China $1.457B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.416B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.406B 0.00
PureTech Health (PRTC) United States $1.395B 0.00
Zealand Pharma (ZEAL) Denmark $1.392B 0.00
Inhibrx (INBX) United States $1.387B 0.00
Travere Therapeutics (TVTX) United States $1.362B 0.00
Scholar Rock Holding (SRRK) United States $1.352B 0.00
Sangamo Therapeutics (SGMO) United States $1.341B 0.00
Agenus (AGEN) United States $1.298B 0.00
BioAtla (BCAB) United States $1.240B 0.00
Avid Bioservices (CDMO) United States $1.235B 251.75
Coherus BioSciences (CHRS) United States $1.226B 0.00
Bluebird Bio (BLUE) United States $1.195B 0.00
Absci (ABSI) United States $1.170B 0.00
RAPT THERAPTICS (RAPT) United States $1.145B 0.00
MannKind (MNKD) United States $1.138B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.138B 0.00
Repare Therapeutics (RPTX) Canada $1.138B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.129B 0.00
Precigen (PGEN) United States $1.126B 0.00
Fulcrum Therapeutics (FULC) United States $1.116B 0.00
Northwest Biotherapeutics (NWBO) United States $1.112B 0.00
ImmunityBio (IBRX) United States $1.065B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Nkarta (NKTX) United States $0.996B 0.00
IDEAYA Biosciences (IDYA) United States $0.996B 0.00
Prometheus Biosciences (RXDX) United States $0.971B 0.00
Merus (MRUS) Netherlands $0.968B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.939B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.910B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.904B 28.02
BeyondSpring (BYSI) United States $0.880B 0.00
Avidity Biosciences (RNA) United States $0.860B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.826B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.822B 0.00
Curis (CRIS) United States $0.768B 0.00
Precision BioSciences (DTIL) United States $0.749B 0.00
Cara Therapeutics (CARA) United States $0.748B 93.31
Amryt Pharma (AMYT) United Kingdom $0.745B 0.00
Keros Therapeutics (KROS) United States $0.727B 0.00
AnaptysBio (ANAB) United States $0.720B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.699B 0.00
Mersana Therapeutics (MRSN) United States $0.697B 0.00
Pliant Therapeutics (PLRX) United States $0.683B 0.00
Akoya Biosciences (AKYA) United States $0.673B 0.00
Gritstone Bio (GRTS) United States $0.670B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.662B 12.05
Acumen Pharmaceuticals (ABOS) United States $0.655B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Brooklyn ImmunoTherapeutics (BTX) United States $0.640B 0.00
Adagene (ADAG) China $0.632B 0.00
Pharming Group (PHAR) Netherlands $0.628B 0.00
Affimed (AFMD) Germany $0.624B 0.00
MiMedx (MDXG) United States $0.618B 0.00
Cellectis S.A (CLLS) France $0.616B 0.00
Spero Therapeutics (SPRO) United States $0.612B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
G1 THERAPEUTICS (GTHX) United States $0.604B 0.00
Seres Therapeutics (MCRB) United States $0.597B 0.00
Ambrx Biopharma (AMAM) United States $0.588B 0.00
Bolt Biotherapeutics (BOLT) United States $0.582B 0.00
MeiraGTx Holdings (MGTX) United States $0.577B 0.00
Anika Therapeutics (ANIK) United States $0.573B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.572B 0.00
ALBIREO PHARMA (ALBO) United States $0.570B 0.00
Vaccitech (VACC) United Kingdom $0.566B 0.00
DBV Technologies S.A (DBVT) France $0.564B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
Epizyme (EPZM) United States $0.553B 0.00
Clovis Oncology (CLVS) United States $0.546B 0.00
Inventiva S.A (IVA) France $0.527B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.512B 0.00
AC Immune SA (ACIU) Switzerland $0.499B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Verastem (VSTM) United States $0.488B 0.00
Cel-Sci (CVM) United States $0.486B 0.00
Selecta Biosciences (SELB) United States $0.480B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.479B 0.00
XBiotech (XBIT) United States $0.476B 0.00
Clene (CLNN) United States $0.472B 0.00
Geron (GERN) United States $0.455B 0.00
Innate Pharma S.A (IPHA) France $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
ChromaDex (CDXC) United States $0.431B 0.00
Codiak BioSciences (CDAK) United States $0.427B 0.00
Arbutus Biopharma (ABUS) United States $0.427B 0.00
SQZ Biotechnologies (SQZ) United States $0.422B 0.00
Oncobiologics (OTLK) United States $0.421B 0.00
Compugen (CGEN) Israel $0.420B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.414B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.405B 0.00
BioDelivery Sciences (BDSI) United States $0.403B 12.39
Starpharma Holdings (SPHRY) Australia $0.402B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.396B 0.00
Cue Biopharma (CUE) United States $0.394B 0.00
Athenex (ATNX) United States $0.389B 0.00
Clearside Biomedical (CLSD) United States $0.387B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.384B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.357B 9.75
Cybin (CYBN) Canada $0.357B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.348B 0.00
Opthea (OPT) Australia $0.344B 0.00
Neoleukin Therapeutics (NLTX) United States $0.342B 0.00
Theratechnologies (THTX) Canada $0.341B 0.00
Syros Pharmaceuticals (SYRS) United States $0.338B 0.00
Athersys (ATHX) United States $0.337B 0.00
Fortress Biotech (FBIO) United States $0.331B 0.00
Cogent Biosciences (COGT) United States $0.331B 0.00
CytomX Therapeutics (CTMX) United States $0.330B 0.00
Prima BioMed (IMMP) Australia $0.328B 0.00
Angion Biomedica (ANGN) United States $0.328B 0.00
INmune Bio (INMB) United States $0.322B 0.00
AquaBounty Technologies (AQB) United States $0.297B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.292B 0.00
Beyond Air (XAIR) United States $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
XOMA (XOMA) United States $0.275B 115.71
Checkpoint Therapeutics (CKPT) United States $0.271B 0.00
Cardiff Oncology (CRDF) United States $0.266B 0.00
IBio (IBIO) United States $0.253B 0.00
Frequency Therapeutics (FREQ) United States $0.244B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.241B 0.00
Kamada (KMDA) Israel $0.240B 20.00
OVID THERAPEUTC (OVID) United States $0.234B 2.05
Kaleido Biosciences (KLDO) $0.232B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
Adicet Bio (ACET) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.219B 0.00
NextCure (NXTC) United States $0.204B 0.00
Seelos Therapeutics (SEEL) United States $0.202B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.199B 0.00
Talis Biomedical (TLIS) United States $0.195B 0.00
OSMOTICA PHARM (OSMT) United States $0.192B 0.00
TELA Bio (TELA) United States $0.184B 0.00
SESEN BIO, INC (SESN) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
ObsEva SA (OBSV) Switzerland $0.177B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
ATyr Pharma (LIFE) United States $0.174B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
VolitionRX (VNRX) United States $0.168B 0.00
Enzo Biochem (ENZ) United States $0.168B 49.57
Synlogic (SYBX) United States $0.167B 0.00
Aptinyx (APTX) United States $0.166B 0.00
Galena Biopharma (SLS) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
TScan Therapeutics (TCRX) United States $0.161B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.157B 0.00
Erytech Pharma SA (ERYP) France $0.153B 0.00
Leap Therapeutics (LPTX) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.150B 0.00
Vascular Biogenics (VBLT) Israel $0.149B 0.00
LogicBio Therapeutics (LOGC) United States $0.148B 0.00
Dyadic (DYAI) United States $0.148B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.144B 0.00
Applied Genetic Technologies (AGTC) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Strongbridge Biopharma (SBBP) United States $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.140B 0.00
Novogen (KZIA) Australia $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Cyclerion Therapeutics (CYCN) United States $0.134B 0.00
Purple Biotech (PPBT) Israel $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.126B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Eton Pharmaceuticals (ETON) United States $0.125B 0.00
Yumanity Therapeutics (YMTX) United States $0.124B 0.00
X4 Pharmaceuticals (XFOR) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.123B 250.50
Exicure (XCUR) United States $0.122B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.115B 6.59
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
Palatin Technologies (PTN) United States $0.105B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Lumos Pharma (LUMO) United States $0.093B 0.00
Celsion (CLSN) United States $0.091B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Aptevo Therapeutics (APVO) United States $0.085B 0.00
Adocia (ADOCY) France $0.083B 0.00
Liminal BioSciences (LMNL) Canada $0.083B 0.00
Statera Biopharma (STAB) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.076B 0.00
Advaxis (ADXS) United States $0.076B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Vyant Bio (VYNT) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Longeveron (LGVN) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
Celyad SA (CYAD) Belgium $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Enveric Biosciences (ENVB) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.09
Genetic Technologies (GENE) Australia $0.051B 0.00
Antibe Therapeutics (ATBPF) Canada $0.050B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
BioCardia (BCDA) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.048B 0.00
ARIDIS PHARMACT (ARDS) United States $0.047B 0.00
Vallon Pharmaceuticals (VLON) United States $0.045B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.043B 0.00
Soligenix (SNGX) United States $0.043B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.034B 0.00
Timber Pharmaceuticals (TMBR) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.031B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.030B 0.00
GeoVax Labs (GOVX) United States $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.015B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00